We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > PPI

News List

Half of Patients on PPIs for GERD Still Have Persistent Symptoms drugs
December 25, 2019
Gastroesophageal reflux disorder (GERD) symptoms are common, and more than half of patients taking daily proton pump inhibitor (PPI) therapy continue to experience persistent symptoms, according to a study published online in Gastroenterology.
PPI Use for Up to Three Years Safe During Anticoagulant Tx drugs
June 18, 2019
PPI Use for Up to Three Years Safe During Anticoagulant Tx.
AstraZeneca signs $922m licensing deal with Grünenthal pharmaceutical-technology
November 01, 2018
AstraZeneca has announced plans to sell certain prescription medicine rights for Nexium and Vimovo to German pharmaceutical company Grünenthal Group under a $922m deal...
LonzaNEWS Long-term use of PPIs linked to stomach cancer europeanpharmaceuticalreview
November 01, 2017
The long-term use of proton pump inhibitors, a class of drugs commonly used to treat acid reflux, is linked to the risk of developing stomach cancer…
Common acid reflux medications promote chronic liver disease europeanpharmaceuticalreview
October 11, 2017
Researchers have discovered evidence that stomach acid suppression alters specific gut bacteria in a way that promotes liver injury and progression of three types of chronic liver disease…